Bazemore Robert B has filed 16 insider transactions across 3 companies since May 2023.
Most recent transaction: a purchase of 123731 shares of Akari Therapeutics Plc ($AKTX) on December 16, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Director | P | Pre-Funded Warrants to purchase ADRs | 123731 | $0.40 | 123,731.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Director | P | Warrants to purchase American Depositary Shares ("ADRs") | 123731 | $0.00 | 123,731.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Director | P | Pre-Funded Warrants to purchase ADRs | 30932 | $0.40 | 30,932.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Director | P | Warrants to purchase ADRs | 30932 | $0.00 | 30,932.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| June 18, 2025 | ARDELYX, INC. | $ARDX | Bazemore Robert B | Director | A | Common Stock | 41551 | $0.00 | 41,551.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | ARDELYX, INC. | $ARDX | Bazemore Robert B | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| May 21, 2025 | Nuvation Bio Inc. | $NUVB | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Not found | A | Series B Warrants (Right to Buy) | 44642 | $1.12 | 44,642.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Not found | A | Series A Warrants (Right to Buy) | 44642 | $1.12 | 44,642.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Not found | A | American Depositary Shares representing Ordinary Shares | 44642 | $1.12 | 44,642.0000 | 0 | 9999.99% | 0.00% |
| Sept. 17, 2024 | Akari Therapeutics Plc | $AKTX | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 5000000 | $0.00 | 5,000,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Nuvation Bio Inc. | $NUVB | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 200801 | $0.00 | 200,801.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | ARDELYX, INC. | $ARDX | Bazemore Robert B | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | Nuvation Bio Inc. | $NUVB | Bazemore Robert B | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |